Atlas Trials

Validation of Bulbicam for DR- and AMD-patients

Clinical trial NCT05441072 · COMPLETED

Trial details

NCT number
NCT05441072
Sponsor
Meddoc
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetic RetinopathyAge-Related Macular Degeneration
Start date
2022-12-19
Primary completion
2023-05-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.